Evidence map›Paper›PMID 27357147›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2016

Contamination of DNase Preparations Confounds Analysis of the Role of DNA in Alum-Adjuvanted Vaccines.

Laura E Noges, Janice White, John C Cambier, John W Kappler, Philippa Marrack

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it, 16 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Emerging concepts in the science of vaccine adjuvants.Nature reviews. Drug discovery · 2021
    Review
  6. Article
  7. Article
  8. Neutrophil cytoplasts induce TScience immunology · 2018
    Article
  9. Article
  10. Old and new adjuvants.Current opinion in immunology · 2017
    Review
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Laura E NogesDepartment of Biomedical Research, National Jewish Health, Denver, CO 80206; Department of Immunology and Microbiology, University of Colorado Anschutz Medical Campus, Aurora, CO 80045; and.
Janice WhiteDepartment of Biomedical Research, National Jewish Health, Denver, CO 80206;
John C CambierDepartment of Biomedical Research, National Jewish Health, Denver, CO 80206; Department of Immunology and Microbiology, University of Colorado Anschutz Medical Campus, Aurora, CO 80045; and.ORCID 0000-0002-7803-242X
John W KapplerDepartment of Biomedical Research, National Jewish Health, Denver, CO 80206; Department of Immunology and Microbiology, University of Colorado Anschutz Medical Campus, Aurora, CO 80045; and Howard Hughes Medical Institute, National Jewish Health, Denver, CO 80206.
Philippa MarrackDepartment of Biomedical Research, National Jewish Health, Denver, CO 80206; Department of Immunology and Microbiology, University of Colorado Anschutz Medical Campus, Aurora, CO 80045; and Howard Hughes Medical Institute, National Jewish Health, Denver, CO 80206 marrackp@njhealth.org.
National Jewish Health · USHoward Hughes Medical Institute · US

Funding

University of Colorado Cancer Center Support Grant - Lung Cancer Patient-Derived Xenografts with Autologous Human Immune SystemsP30CA046934 · NCI · UNIVERSITY OF COLORADO DENVER · PI James V Degregori · 1988 to 2026
$117.0M
THE REGULATION OF V ALPHA 7 EXPRESSING T CELLSP01AI022295 · NIAID · NATIONAL JEWISH HEALTH · PI CAMBIER, JOHN C · 1985 to 2011
$11.7M
CHARACTERISTICS OF T CELL RECEPTORSR01AI018785 · NIAID · NATIONAL JEWISH HEALTH · PI MARRACK, PHILIPPA C. · 1985 to 2022
$7.3M
Infectious Agents and B Cell AnergyR01AI077597 · NIAID · UNIVERSITY OF COLORADO DENVER · PI CAMBIER, JOHN C · 2010 to 2014
$1.9M
CHARACTERISTICS OF T-CELL RECEPTORSR37AI018785 · NIAID · NATIONAL JEWISH HEALTH · PI MARRACK, PHILIPPA C. · 1992 to 2001
$522k
Mouse modeling of a human STING gene variant for infectious diseaseR21AI099346 · NIAID · UNIVERSITY OF COLORADO DENVER · PI CAMBIER, JOHN C · 2012 to 2013
$410k
Characteristics of T Cell ReceptorsR56AI018785 · NIAID · NATIONAL JEWISH HEALTH · PI MARRACK, PHILIPPA C. · 2012 to 2012
$410k
Howard Hughes Medical InstituteNCI NIH HHS P30 CA046934NIAID NIH HHS HHSN272201300006CNIAID NIH HHS P01 AI022295NIAID NIH HHS R01 AI018785NIAID NIH HHS R01 AI077597NIAID NIH HHS R21 AI099346NIAID NIH HHS R37 AI018785NIAID NIH HHS R56 AI018785
6 · The paper itself

Abstract

Aluminum salt (alum) adjuvants have been used for many years as adjuvants for human vaccines because they are safe and effective. Despite its widespread use, the means by which alum acts as an adjuvant remains poorly understood. Recently, it was shown that injected alum is rapidly coated with host chromatin within mice. Experiments suggested that the host DNA in the coating chromatin contributed to alum's adjuvant activity. Some of the experiments used commercially purchased DNase and showed that coinjection of these DNase preparations with alum and Ag reduced the host's immune response to the vaccine. In this study, we report that some commercial DNase preparations are contaminated with proteases. These proteases are responsible for most of the ability of DNase preparations to inhibit alum's adjuvant activity. Nevertheless, DNase somewhat reduces responses to some Ags with alum. The effect of DNase is independent of its ability to cleave DNA, suggesting that alum improves CD4 responses to Ag via a pathway other than host DNA sensing.

Indexed as

DeoxyribonucleasesAdjuvants, ImmunologicAlum CompoundsAnimalsAntigensCD4-Positive T-LymphocytesCD8-Positive T-LymphocytesDNADrug ContaminationEnzyme-Linked Immunosorbent AssayFemaleLymphocyte ActivationMass SpectrometryMiceMice, Inbred C57BLVaccinesAdjuvants, ImmunologicAlum Compoundsaluminum sulfateAntigensDeoxyribonucleasesDNAVaccines

Identifiers

PMID27357147
PMCPMC4974487
OpenAlexW2475219939

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.